---
title: "Edgewise Therapeutics Insider Sold Shares Worth $276,776, According to a Recent SEC Filing"
date: "2025-02-08 05:43:07"
summary: "Alan J Russell, Director, Chief Scientific Officer, on February 05, 2025, sold 9,215 shares in Edgewise Therapeutics  for $276,776. Following the Form 4 filing with the SEC, Russell has control over a total of 14,863 common shares of the company, with 14,863 shares held directly. SEC Filing:www.sec.gov/Archives/edgar/data/1710072/000156218025001026/xslF345X05/primarydocument.xml"
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Alan J Russell, Director, Chief Scientific Officer, on February 05, 2025, sold 9,215 shares in Edgewise Therapeutics for $276,776. Following the Form 4 filing with the SEC, Russell has control over a total of 14,863 common shares of the company, with 14,863 shares held directly.

SEC Filing:

[www.sec.gov/Archives/edgar/data/1710072/000156218025001026/xslF345X05/primarydocument.xml](https://www.sec.gov/Archives/edgar/data/1710072/000156218025001026/xslF345X05/primarydocument.xml)

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3313064:0/)
